Here's a company that was valued at 1.4 Billion. T
Post# of 72440
https://endpts.com/prothenas-lead-drug-neod00...%20salvage
So, even after dropping over 62%, this company with a catastrophic clinical trial failure, and two drugs that are very unlikely to work, is still valued at FIVE HUNDRED AND FIFTY PERCENT the value of IPIX, with its 3 drugs that have have multiple clinical trial SUCCESSES.
Sheesh. Efficient markets, right.